Global Diagnostic Market Statistics - Quantifying Australia's Place in International Trade
The IVD global market revenue was estimated at approximately $USD 53 billion in 2013 and with a compound annual growth rate of 5.34%, by 2020 this will be in the vicinity of $USD 75 billion. Australia is estimated to be comprise about 2% of the world market, putting Australian market revenue at close to $USD2 billion. The Global Diagnostic Market Statistics (GDMS) project being supported by Pathology Technology Australia is focused on determining a substantiated figure on the size of the Australian market. The IVD Industry in Australia needs this figure to underpin its approaches to government for improved reimbursement and to facilitate innovation in our sector of industry.
One of the goals of Pathology Technology Australia is to 'drive industry development'. One of the ways in which we can focus better government attention and initiatives for our industry is to be able to quantify our contribution to the Australian economy. however, we can't achieve this without knowing the size of our industry. Therefore, IVD Australia has committed to funding member participation in the EDMA Global Market Statistics program. The outcomes are useful, not only for the industry as a whole, but also your company.
The inaugural Australian Industry Report 2013-2014 was released on February 26, 2016 at our February Networking Event.
Access a copy here
GDMS is important …
One consistent set of reports for Australia
Understand company performance versus competition based on reliable country information – Is your country growth in-line with market growth?
Reliable basis for strategy development activities, planning and budgeting